| 81 |
Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) |
2017 |
| 82 |
Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) |
2017 |
| 83 |
Prevalence and Risk Factors of Depression and Anxiety in Hepatitis C Patients Receiving Pegylated Interferon Alpha (IFN-a) |
2017 |
| 84 |
Prevalence of Occult HBV Infection Among Chronic Hepatitis C Patients in Upper Egypt |
2017 |
| 85 |
Prevalence, knowledge, and attitude toward complementary and alternative medicine use among patients with chronic hepatitis C in Upper Egypt |
2017 |
| 86 |
The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anemia in chronic hepatitis C Egyptian patients |
2017 |
| 87 |
Toll Like receptor 3 polymorphisms in hepatitis B virus infection |
2017 |
| 88 |
Types and microbiological spectrum of infections in patients
with cirrhosis: A single-centre experience in Upper Egypt |
2017 |
| 89 |
A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis. |
2016 |
| 90 |
Prevalence of occult hepatitis C virus in patients with HCV - antibody positivity and serum HCV RNA negativity |
2016 |
هل لديك سؤال ؟
